VFactor Health Announces Clinician-Led Framework to Support Women Using GLP-1 Medications

Delray Beach, Florida - April 8, 2026 - VFactor Health announced its structured, clinician-developed framework to support women using or considering GLP-1 medications. The initiative responds to a growing national trend: increasing numbers of women are prescribed GLP-1 medications without receiving guidance on how to manage nutrition, metabolic changes, or common challenges associated with appetite suppression.

Image: https://www.globalnewslines.com/uploads/2026/04/06f6f99a4a69355fa32128669b597298.jpg

According to recent national data [https://www.kff.org/health-costs/poll-1-in-8-adults-say-theyve-taken-a-glp-1-drug-including-4-in-10-of-those-with-diabetes-and-1-in-4-of-those-with-heart-disease/], an estimated 12-15% of U.S. adults have used a GLP-1 medication, reflecting rapid growth in the category. While these medications are widely prescribed, many individuals begin treatment with limited information about how reduced caloric intake may impact energy levels, nutrient intake, or overall metabolic stability. Research also indicates that discontinuation rates are high, with nearly 58% of users stopping treatment before reaching a meaningful duration.

VFactor Health's new framework was developed to address the lack of structured support many women encounter while navigating GLP-1 use. The company reports that a significant number of patients rely on informal sources, such as social media or peer recommendations, to manage side effects, adjust routines, or understand dietary needs. Concerns also extend to nutritional adequacy. Studies note that significant appetite suppression can reduce intake of protein, vitamins, and essential minerals, potentially contributing to decreased lean mass without proper nutritional planning [https://www.medscape.org/viewarticle/glp-1-therapy-use-and-nutrient-deficiencies-team-based-2026a100093z?page=1&impID=8223035&sso=true&uac=476798AV&src=wnl_tpal_260328_mscpedu]. The program aims to provide an organized, clinician-guided structure that helps participants better interpret changes in appetite, maintain adequate nutrient intake, and understand how to support their metabolism during various phases of GLP-1 use.

"Many women begin GLP-1 therapy without clear expectations or accessible education about how these medications affect metabolic patterns," said Veronique Yu, PA-C, RD, Founder of VFactor Health. "This framework was created to offer clarity and a consistent path of guidance in an area where many patients feel uncertain."

The announcement also comes as new evidence underscores the importance of structured support. Clinical studies from the National Institutes of Health [https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf] indicate that side effects such as nausea, digestive discomfort, fatigue, and hair thinning are common, and that changes in eating patterns may influence lean-muscle preservation and overall well-being. VFactor Health's program provides organized educational components intended to help users better understand these factors while working with qualified clinicians.

VFactor Health will also introduce a series of live educational webinars in the coming weeks. These sessions will provide neutral, evidence-based discussions about GLP-1 usage trends and the role of structured support in helping patients navigate their treatment experience.

For women seeking guidance or wanting to learn more about structured support during GLP-1 therapy, visit the dedicated landing page: https://vfactorhealth.com/glp-1-page [https://vfactorhealth.com/glp-1-page]

About VFactor Health

VFactor Health is a clinician-led program based in Delray Beach, Florida, focused on providing structured metabolic education for women using or considering GLP-1 medications. The organization was founded to address gaps in patient guidance and to offer a consistent, evidence-based framework to help individuals better understand their metabolic needs throughout treatment.

Image: https://www.globalnewslines.com/uploads/2026/04/8a41ebebfb62db89137516eade988ed7.jpg
Media Contact
Company Name: VFactor Health
Contact Person: Veronique Yu
Email: Send Email [http://www.universalpressrelease.com/?pr=vfactor-health-announces-clinicianled-framework-to-support-women-using-glp1-medications]
Phone: 561-702-3338
Country: United States
Website: https://vfactorhealth.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.